Ascentage Pharma Group International AAPG
NASDAQ AAPG
$15.90 -0.59 (-3.63%)
As of: Oct 1, 2026 · 2:20 PM EDT

Ascentage Pharma Group International (AAPG) Current Deferred Revenue (2023 - 2026)

Updated

Ascentage Pharma Group International's Current Deferred Revenue was $10.25 million in Q2 2026, up 95.9% from $5.23 million a year earlier.

Analysis

Ascentage Pharma Group International (AAPG) Current Deferred Revenue (2023 - 2026) Analysis & Trends

At the end of FY2025, Current Deferred Revenue at Ascentage Pharma Group International came in at $5.36 million, up 4.4% from FY2024.

  • In earlier years, Current Deferred Revenue was $5.14 million in FY2024 (-5.5%) and $5.44 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Ascentage Pharma Group International 1.55 Bn 517.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.25 Mn
Dec 31, 2025 5.29 Mn
Jun 30, 2025 5.23 Mn
Dec 31, 2024 5.22 Mn
Dec 31, 2023 5.33 Mn
API Access

Ascentage Pharma Group International Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=AAPG&period=max&api_key=YOUR_API_KEY